About Us

The Alpha-1 Research Program was established at the University of Florida College of Medicine in Gainesville, Florida in 1998 by the Alpha-1 Foundation.
The Program, under the direction of Mark L. Brantly, M.D., is devoted to the study of lung and liver disease associated with Alpha-1 Antitrypsin (AAT) Deficiency. Its resources and services are an important access point for the national and international medical and scientific communities.

Mission

Our mission is to improve the lives of alpha-antitrypsin individuals and their families through research and service by developing new therapies that target lung and liver disease associated with alpha-1 antitrypsin deficiency using a combination of basic and clinical research.

Services and Resources

The Alpha-1 Research Program resources and services include: